Status:
COMPLETED
Immersive Versus Passive Virtual Reality on Upper Limb Pain and Range of Motion in Pediatric Burn
Lead Sponsor:
Cairo University
Conditions:
Virtual Reality
Immersive Virtual Reality
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
The purpose of the present study was to declare the difference between using immersive virtual reality vs passive virtual reality on pain management and improvement of ROM post physiotherapy exercise ...
Detailed Description
Burn injuries are devastating and cause long-term damage to health. Thermal injuries, caused by hot liquids, solids, or fire, account for the majority of these injuries. Around 11 million burn cases o...
Eligibility Criteria
Inclusion
- Sixty patients have 2nd degree thermal burn injury, from both genders their ages will be ranged from 7 - 17 years old.
- They will be diagnosed by their physicians with 2nd degree thermal burn injury affecting upper limbs and referred for physical therapy management .
- TBSA calculated up to 9 for one upper limb.
- The patients will be in the acute stage post burn injury; the duration of burn will be 3 weeks post injury.
- Medically and psychologically stable patients
Exclusion
- The potential participants will be excluded if they meet one of the following criteria:
- Cardiac diseases.
- Hand Burn
- Exposed tendons.
- Patients who suffer from skin diseases, diabetes, varicose veins, and peripheral vascular diseases.
- Patients with life threatening disorders as renal failure, myocardial infarction or other similar diseases.
- Patients with facial burn.
- Patients will have an inability to tolerate visual stimulation (e.g., susceptibility to migraines aggravated by light) or inability to tolerate the head mounted display (e.g., sensitivity to touch around the face and head).
- Patients with visual or auditory disorders.
- Patients with unstable fractures.
- Central Nervous System (CNS) problems.
- Patients with medical red flags as severe psychiatric disorder or cognitive deficits .
- Medically unstable and uncooperative patients.
Key Trial Info
Start Date :
March 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06612892
Start Date
March 10 2024
End Date
September 10 2024
Last Update
September 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haytham Mostafa Youssef
Cairo, Egypt